As part of a pilot campaign, the ACTG AEC Communications Subcommittee is creating a library of ACTG study result slides that will provide insight into the broad range of our work. These short, lay-language slides will be public facing, here on the ACTG public website, and for site use in presentations to various audiences (including Community Advisory Boards). The slide decks below are available for download. We’ll be updating this page with new slide decks, so continue to check back regularly!
-
To see study results from A5305 click here.
Read more
-
To see results of A5333s click here.
Read more
-
A5336: A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
To see study results from A5336 click here.
Read more
-
A5349: Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis
To see study results from A5349 click here.
Read more
-
REPRIEVE TRIAL Cardiovascular Disease Risk and Prevention in Inflammation: The REPRIEVE Trial in HIV
To see study results from the REPRIEVE trial click here.
Read more
-
-
A5401/Symptom and Viral Rebound in Untreated COVID-19 Infection
To see study results from A5401, click here
-
To see study results from A5321, click here
-
To see study results from A5371, click here